Clopidogrel with or without omeprazole in coronary artery disease. - Wikidata - awgldk - TriplyDB

Clopidogrel with or without omeprazole in coronary artery disease.

Clopidogrel with or without omeprazole in coronary artery disease.

http://www.wikidata.org/entity/Q34660303

about

Impact of proton pump inhibitors on efficacy of clopidogrel: Review of evidence Clopidogrel and interaction with proton pump inhibitors: comparison between cohort and within person study designs Overutilization of proton-pump inhibitors: what the clinician needs to know Safety of Digestive Endoscopy following Acute Coronary Syndrome: A Systematic Review Current status of high on-treatment platelet reactivity in patients with coronary or peripheral arterial disease: Mechanisms, evaluation and clinical implications Pharmacodynamic impacts of proton pump inhibitors on the efficacy of clopidogrel in vivo--a systematic review Clopidogrel and proton pump inhibitors--where do we stand in 2012?Current perspectives in NSAID-induced gastropathy Treatment and prevention of gastrointestinal bleeding in patients receiving antiplatelet therapy Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy Potential for developing purinergic drugs for gastrointestinal diseases Proton pump inhibitors in prevention of low-dose aspirin-associated upper gastrointestinal injuries Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic review Effects of combined aspirin and clopidogrel therapy on cardiovascular outcomes: a systematic review and meta-analysis Effects of Clopidogrel and Proton Pump Inhibitors on Cardiovascular Events in Patients with Type 2 Diabetes Mellitus after Drug-Eluting Stent Implantation: A Nationwide Cohort Study Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015.Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials.Dexlansoprazole MR for the management of gastroesophageal reflux disease.Aspirin and proton pump inhibitor combination therapy for prevention of cardiovascular disease and Barrett's esophagus.Clopidogrel: the data, the experience, and the controversies.Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies.Clinical Implications of Emerging Data on the Safety of Proton Pump Inhibitors.Platelet distribution width as the prognostic marker in coronary bifurcation treatment.Recent advances in antithrombotic therapy after acute coronary syndrome.The potential interaction between clopidogrel and proton pump inhibitors: a systematic review.Pantoprazole Does Not Reduce the Antiplatelet Effect of Clopidogrel: A Randomized Controlled Trial in Korea Antiplatelet drug interactions with proton pump inhibitors Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis.Risk score to predict gastrointestinal bleeding after acute ischemic stroke Combined influence of proton-pump inhibitors, calcium-channel blockers and CYP2C19*2 on on-treatment platelet reactivity and on the occurrence of atherothrombotic events after percutaneous coronary intervention.One fifth of hospitalizations for peptic ulcer-related bleeding are potentially preventable.Consensus on control of risky nonvariceal upper gastrointestinal bleeding in Taiwan with National Health Insurance.Pharmacogenetics and clopidogrel response in patients undergoing percutaneous coronary interventions.Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis.Prevention of upper gastrointestinal haemorrhage: current controversies and clinical guidance State-of-the-art management of acute bleeding peptic ulcer disease.

P2860

Q24608981-83551E9E-429F-4FE1-81FC-C8EC0E288C51 Q24633087-488611C8-D50C-44CA-B180-C22313419171 Q24634086-D4DBF032-F7C4-42A0-A525-710E1D8B8216 Q26742094-A6057F5A-CD5B-49C4-A5E1-0F84141D7913 Q26771106-17FB8AB6-71BF-4E44-A46F-84BFEF549595 Q26822474-14CBBC04-8F65-4619-9374-602EA52BF3E0 Q26825728-D53B01E3-A8FA-4C36-A2E7-F0A4BC7AE03E Q26827673-B1646AAE-41FF-4E15-B647-7BEA3048E152 Q26866350-B6F9BB16-B397-42F9-998A-A152EB4D7689 Q26995752-756E3373-486E-49ED-A8CA-BA399B4E9B05 Q26998331-3F728B16-34D8-4C0D-86DE-1926944F6929 Q27000719-D3E80B00-CF7E-4F62-BEC6-62D61112260E Q27004834-02A42CF8-9AF4-46A1-B849-C373D0084B59 Q28287257-854B469A-89A2-4D72-90A1-95222910147A Q28480610-C5BA579D-1A25-484E-9C3C-994EF8E5F770 Q28547539-303E8CB6-C738-498D-BD11-165A81209996 Q28548045-D1BE10C1-BCFA-4315-BD57-672FBEA6A75E Q30249468-4D4D11A2-0CF1-4725-8B3D-1F409FD43698 Q30421742-917F0D24-B049-4CF0-B9F1-DBD62784640D Q30453948-A2FBCBF9-42CA-4D5B-90E2-2F371863C963 Q30457290-9D924AC0-CCE5-419B-A675-D2EB61BF33F3 Q30573045-D2DC7D44-DA70-4811-9AC3-47956F5BA880 Q30928614-3DC3FA7D-A9C4-4703-845C-F85BE3D50C88 Q31157434-29E8CC45-E82B-4A43-88F1-C19F593B37C4 Q33442212-A11B9CEA-F99B-4790-9F0A-3E5A650DF6F0 Q33590548-DAAC5BDB-C902-4B3F-879E-B03EBA580F83 Q33763929-A9EAE121-8800-4A40-BB47-CA34A5CC8B0F Q33853179-5EBB3B4F-7827-4E83-A594-7467F60D1044 Q33948811-65700446-9C06-417A-95BA-8FB0DB7FD6B8 Q33982372-38D225E0-6616-4A10-965B-260DE753D0E7 Q33997632-76C190ED-7CC1-472C-8E64-353F1706D38F Q33997642-CC33E3ED-E2C1-46EE-9818-592FCD75158F Q34036732-37E3C479-B1B8-4970-8300-B30953C6C2BF Q34100357-492827C1-40EB-452C-A004-4742467BFA40 Q34161006-4BF989BA-58A8-4FE7-A434-8458766AC5D5 Q34169062-FAD46F8A-6997-4A5E-B934-DFFD2B24DFF1 Q34486149-BD1A6174-DDB0-46AD-9659-4030915DF917 Q34510524-04B5A260-E00D-43A0-A251-78FCE6D89BF6 Q34655792-D5B124B0-8A5E-49C8-83B8-4B8E1C719D9D Q34656150-0AC52105-7E8B-44B6-ADBC-E219278D6901

P2860

Clopidogrel with or without omeprazole in coronary artery disease.

http://www.wikidata.org/entity/Q34660303

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Clopidogrel with or without omeprazole in coronary artery disease.

@ast

Clopidogrel with or without omeprazole in coronary artery disease.

@en

Clopidogrel with or without omeprazole in coronary artery disease.

@nl

type

label

Clopidogrel with or without omeprazole in coronary artery disease.

@ast

Clopidogrel with or without omeprazole in coronary artery disease.

@en

Clopidogrel with or without omeprazole in coronary artery disease.

@nl

prefLabel

Clopidogrel with or without omeprazole in coronary artery disease.

@ast

Clopidogrel with or without omeprazole in coronary artery disease.

@en

Clopidogrel with or without omeprazole in coronary artery disease.

@nl

P1433

Q34660303-CA25234A-BC2E-4A62-838C-C9FF33F06E22

P1476

Q34660303-9B53F668-177A-4809-9D52-C1ED9C37961E

P2093

Q34660303-095C2842-F236-4321-90D4-03346614A617

Q34660303-146B3343-57DD-443B-A616-57BEA4D7463E

Q34660303-1D7A0456-C2BF-4BE4-8BAF-38F31DD5F632

Q34660303-34D909E7-392D-4604-8C3D-A53A358BF81B

Q34660303-57A51716-A9E4-433B-93EF-1F69B616E908

Q34660303-67E260E3-ADA2-4517-981D-A7E60A528BB5

Q34660303-71B319EC-5A09-4CE9-BB12-9710544F186A

Q34660303-831BE75C-DC5F-40A1-BC2D-A722C7ECF81B

Q34660303-9D2404AD-CB2C-4C49-AFCE-80835BD0EFE5

Q34660303-9D84BC6F-6702-455F-91A7-AC7F2179B45E

P304

Q34660303-B3E893DB-00B1-4603-888E-92D58D8F6ACB

P31

Q34660303-51FFE3F8-F8A3-4EC5-82C4-057D7CA99D49

P356

Q34660303-43C1B9A9-7D12-4665-B5BE-069C673BE09D

P407

Q34660303-03C96AFE-B72F-4A28-9303-0CB13A0B01F8

P433

Q34660303-A2495889-3AFA-46F3-A5B4-455FD14A496D

P478

Q34660303-86F833ED-CB9D-414A-9F3E-27D8E74FF3DA

P577

Q34660303-718271B2-9CD4-47E4-A043-5058F7C5561D

P698

Q34660303-AAB82AD3-A887-4F5A-A96C-AA64BE93B349

P921

Q34660303-0C917864-DE74-49B5-ADB3-A8DA149D2A60

P356

P1433

The New England Journal of Medicine

P1476

Clopidogrel with or without omeprazole in coronary artery disease.

@en

P2093

Angel Lanas

http://www.w3.org/2001/XMLSchema#string

Benjamin M Scirica

http://www.w3.org/2001/XMLSchema#string

Byron L Cryer

http://www.w3.org/2001/XMLSchema#string

COGENT Investigators

http://www.w3.org/2001/XMLSchema#string

Charles F Contant

http://www.w3.org/2001/XMLSchema#string

Christopher P Cannon

http://www.w3.org/2001/XMLSchema#string

Deepak L Bhatt

http://www.w3.org/2001/XMLSchema#string

Loren Laine

http://www.w3.org/2001/XMLSchema#string

Marc Cohen

http://www.w3.org/2001/XMLSchema#string

Mark A Goldsmith

http://www.w3.org/2001/XMLSchema#string

P304

1909-1917

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1007964

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

363

http://www.w3.org/2001/XMLSchema#string

P577

2010-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20925534

http://www.w3.org/2001/XMLSchema#string

P921